Decline in the incidence of renal failure due to amyloidosis associated with inflammatory rheumatic diseases

Amyloid

Volumn 18, Issue SUPPL. 1, 2011, Pages 229-230

  Immonen, K ^a   Pettersson, T ^b   Finne, P ^b   Gronhagen Riska C ^b   Klaukka, T ^c   Kautiainen, H ^d   Hakala, M ^d,e  

^a NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c SOCIAL INSURANCE INSTITUTION   (Finland)

^d RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB;

ABDOMINAL FAT ASPIRATION BIOPSY; AMYLOIDOSIS; ANKYLOSING SPONDYLITIS; ARTICLE; DIALYSIS; DISEASE ASSOCIATION; FINLAND; HUMAN; HUMAN TISSUE; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RHEUMATOID ARTHRITIS;

EID: 79959972399     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.574354     Document Type: Article

References (10)

1. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Hakala M. Amyloidosis in a nationwide-series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology 1999;38:499-503. (Pubitemid 29504833)
2. Savolainen HA, Isomäki HA. Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol 1993;20:1201-1203. (Pubitemid 23278176)
3. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993;52:174-176. (Pubitemid 23094303)
4. Immonen K, Finne P, Hakala M, Kautiainen H, Pettersson T, Grönhagen-Riska C. No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases - data from the Finnish national registry for kidney diseases. J Rheumatol 2008;35:1334-1338. (Pubitemid 352000780)
5. Finne P, Reunanen A, Stenman S, Groop P-H, Grönhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005;14:1782-1787. (Pubitemid 41434624)
6. Laiho K, Tiitinen S, Kaarela K, Helin H, Isomäki H. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 1999;18:122-123. (Pubitemid 29223032)
7. Gottenberg JE, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B, Combe B, Durbach A, Sibilia J, Dougados M, et al. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy. Arhritis Rheum 2003;48:2019-2024. (Pubitemid 36828697)
8. Falck HM, Maury C P J, Teppo A-M, Wegelius O. Correlation of persistently high serum amyloid A and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J 1983;286:1391-1393. (Pubitemid 13128626)
9. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24-29. (Pubitemid 32709735)
10. Koivuniemi R, Paimela L, Suomalainen R, Törnroth T, Leirisalo-Repo M. Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Amyloid 2008;15:262-268.